Aviva Systems Biology Corp.

Company Overview

GenWay Biotech, a top supplier of production and manufacturing services to the life science and diagnostic industries, was acquired by Aviva Systems Biology in 2017. The GenWay services are completely integrated into Aviva, and they collaborate with academic, biopharmaceutical, and diagnostic labs to increase their resources by providing practical knowledge and solutions for:

• Advanced antibody characterization
• Mid- to large-scale synthesis of antibodies and proteins, including the creation of processes
• Development and production of ELISA
• Antigen-antibody fusion 

The ISO 13485 accredited services laboratory provides GMP antibody, protein, and assay manufacturing services. 

GenWay Biotech Inc. is focused on providing protein and antibody solutions. The company produces protein antigens and ligands and develops domain–specific IgY antibodies for immunoaffinity capture, partitioning, detection, and analyses. It also provides antibodies, proteins, ELISA kits, reagents, plasma and plant proteomic products, protein expression, and cell line development. Furthermore, it offers peptides, assay development and contract manufacture and research organization services. GenWay Biotech Inc. was established in 1998 and is headquartered in San Diego, Calif.

Company's Business Segments

• Research Services : This segment of company includes providing Polyclonal and Monoclonal antibodies, ELISA kits, Proteins, Custom services for research needs.